Exploring Staphylococcus aureus pathways to disease for vaccine development. - Test2 - elhamkhani - TriplyDB

Exploring Staphylococcus aureus pathways to disease for vaccine development.

Exploring Staphylococcus aureus pathways to disease for vaccine development.

http://www.wikidata.org/entity/Q36516970

about

Where does a Staphylococcus aureus vaccine stand?The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infection Evaluation of the protective immunity of a novel subunit fusion vaccine in a murine model of systemic MRSA infection.Phagocytosis escape by a Staphylococcus aureus protein that connects complement and coagulation proteins at the bacterial surface Attenuation of Staphylococcus aureus-Induced Bacteremia by Human Mini-Antibodies Targeting the Complement Inhibitory Protein Efb Abscess formation and alpha-hemolysin induced toxicity in a mouse model of Staphylococcus aureus peritoneal infection.Coagulases as determinants of protective immune responses against Staphylococcus aureus.Protein A-specific monoclonal antibodies and prevention of Staphylococcus aureus disease in mice.Vaccination with a UV-irradiated genetically attenuated mutant of Staphylococcus aureus provides protection against subsequent systemic infection.The iron-regulated staphylococcal lipoproteins.Altered immune proteome of Staphylococcus aureus under iron-restricted growth conditions.Essential Domain-Dependent Roles Within Soluble IgG for Superantigen Properties of Staphylococcal Protein A: Resolving the B-Cell Superantigen Paradox

P2860

Q26828726-9551F6F8-9A1B-4C15-81DE-A03AC833A176 Q30415990-970D1FBF-0FD7-4F5D-8B61-65BFD9DA79F0 Q34596203-3991D18C-5643-4B8B-BF8B-B1BC3960C374 Q35063930-EA23D8CD-4A96-49D9-8B2D-AD9E31E535B5 Q35069186-9601673F-359D-45C6-B710-974E657B71EE Q35765208-BE5D0EDB-09C6-4268-AD3A-FCE2A02A3801 Q36277405-FC489207-4E52-4D71-B929-E4D788AD6EF5 Q36277411-27EFBB51-490F-4E63-8148-EC49D05E6F8C Q36277427-FC3B436B-6E57-42C4-A728-375E3444B036 Q36368669-6BC3F986-EC38-4DC4-896F-69A81AEA8D59 Q38037549-6A48E914-C8EC-4BF9-B083-2DEBFCEC0D3E Q50116528-E5E80076-2BC7-4036-9AFE-4E4E4F1817B2 Q57072739-80B4DDB7-C48A-4C7D-AD5A-39E38BABDE3B

P2860

Exploring Staphylococcus aureus pathways to disease for vaccine development.

http://www.wikidata.org/entity/Q36516970

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Exploring Staphylococcus aureus pathways to disease for vaccine development.

@ast

Exploring Staphylococcus aureus pathways to disease for vaccine development.

@en

type

label

Exploring Staphylococcus aureus pathways to disease for vaccine development.

@ast

Exploring Staphylococcus aureus pathways to disease for vaccine development.

@en

prefLabel

Exploring Staphylococcus aureus pathways to disease for vaccine development.

@ast

Exploring Staphylococcus aureus pathways to disease for vaccine development.

@en

P1433

Q36516970-DBD17AD3-E0BA-4A2C-9278-90572A0BB1A2

P1476

Q36516970-FB4B8D59-71A3-4874-B305-6D60C2DE97D3

P2093

Q36516970-18165DAC-F401-48F4-B468-07C5DE50A343

Q36516970-D30915B2-78CF-4AB2-900A-449178957516

P2860

Q36516970-027DABD7-9463-4573-AC51-E9A73CA75BB2

Q36516970-038B099E-7E0E-453A-A5AE-D974A757CC48

Q36516970-04D3108E-B2AB-42F7-934C-2AE48D1B3E04

Q36516970-04E8E957-D0CF-4500-BCE6-A8F342C327DD

Q36516970-056899B4-217B-476E-8820-304AA8AF6276

Q36516970-058C722E-8A8F-4B80-9127-9D81B22692D7

Q36516970-05941B58-A619-4F5D-9721-06CA4217C954

Q36516970-05D0784B-28CF-4049-9538-D3F300A7F1AE

Q36516970-06CB8A3D-C2CC-4EC2-8F56-82A39A9FC6C5

Q36516970-07CA7DE6-7052-427F-8D0B-37DCC8420232

P2888

Q36516970-C20F8CA2-3D62-411B-B771-0EAC58DA6F09

P304

Q36516970-AD8E81D8-962A-4D03-BAAB-9C40C18D4FEA

P31

Q36516970-520974B8-A141-4DFC-B02A-48B89ED745B9

P356

Q36516970-DEE90182-D3FB-4660-BD1F-1ABE73249C26

P433

Q36516970-AB8851D2-643B-4B4C-84CB-5D4A2B3F0DAB

P478

Q36516970-A6A3C05C-664D-4B7A-A4B2-5652D578B401

P50

Q36516970-30A02BB9-8B73-48F9-8541-B6DDA8203BF7

Q36516970-C64B3D5A-2D44-459F-9B20-86C0E8C34EBF

P577

Q36516970-1AD0B6DB-1F72-41C2-A59E-385F118BF1C6

P698

Q36516970-56D49DCB-CD46-4DE8-800C-E87A9CD6F0D7

P932

Q36516970-A787CC3A-514E-41A4-A213-917471B8BFC1

P356

S00281-011-0299-Z

P1433

Seminars in Immunopathology

P1476

Exploring Staphylococcus aureus pathways to disease for vaccine development

@en

P2093

Andrea DeDent

http://www.w3.org/2001/XMLSchema#string

Dominique Missiakas

http://www.w3.org/2001/XMLSchema#string

P2860

The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b

Structure of the cell wall anchor of surface proteins in Staphylococcus aureus

The changing epidemiology of Staphylococcus aureus?

LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity

Hepcidin, a urinary antimicrobial peptide synthesized in the liver

Haptoglobin: a natural bacteriostat

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

Fibrinogen substrate recognition by staphylocoagulase.(pro)thrombin complexes

Novel fluorescent prothrombin analogs as probes of staphylocoagulase-prothrombin interactions

Contribution of coagulases towards Staphylococcus aureus disease and protective immunity

P2888

s00281-011-0299-z

P304

317-333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00281-011-0299-Z

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Olaf Schneewind

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22130613

http://www.w3.org/2001/XMLSchema#string

P932

3539746

http://www.w3.org/2001/XMLSchema#string